IDH2 and central nervous system cancer: Interestingly, glioma samples with IDH mutations showed higher levels of H3K9me3 and H3K27me3 which might potentially explain why 2-HG can inhibit the activity of α-KG-dependent JHDMs, which demethylate histones (Lu et al., 2012).